💨 Abstract

Perspective Therapeutics, Inc. (CATX) reported a $21.5 million loss in the second quarter. The per-share loss was 29 cents, matching Wall Street estimates. Adjusted for discontinued operations, the loss was 30 cents per share, aligning with the average estimate from seven analysts. The company generated $290,000 in revenue.

Courtesy: WTOP Staff